About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 106 record(s)
Req # A-2021-11663
A copy of the release package that was disclosed in response to access to information request file number A-2021-007891.Organization: Patented Medicine Prices Review Board Canada
June 2021
Req # A-2021-11666
A copy of the PMPRB's 6-page Communication Plan, "Modern and Proactive Communications Strategy", dated February 9, 2021 as previously disclosed in a release package in response to an access to information request.Organization: Patented Medicine Prices Review Board Canada
June 2021
Req # A-2021-11668
Copies of the email chain between Michell Levine, Isabel Jaen Raasch, Tanya Potashnik, Douglas Clark, Guillaume Couillard, Riaz Awadia and Elena Lungu having the subject line "Call with IMC this morning", dated December 5, 2019.Organization: Patented Medicine Prices Review Board Canada
June 2021
Req # A-2021-07885
Copies of all briefing notes provided to the Deputy Minister regarding the implementation of the new PMPRB guidelines on July 1, 2021 from January 1, 2021 to April 28, 2021.Organization: Patented Medicine Prices Review Board Canada
May 2021
Req # A-2021-07888
Copies of all briefing notes provided to the Deputy Minister regarding the possible delay in the implementation of the new PMPRB guidelines from January 1, 2021 to April 28, 2021.Organization: Patented Medicine Prices Review Board Canada
May 2021
Req # A-2021-07890
Copies of all emails sent/received from Douglas Clark, Tanya Potashnik, Mitchell Levine and Isabel Jaen Raasch discussing the possible delaying in the implementation of the new PMPRB guidelines from January 1, 2021 to April 28, 2021.Organization: Patented Medicine Prices Review Board Canada
May 2021
Req # A-2021-09406
Copies of emails to/from/cc'ing Douglas Clark, Tanya Potashnik and Mitchell Levine on negative feedback from groups consulted over the new PMPRB guidelines from June 1, 2019 to December 31, 2020.Organization: Patented Medicine Prices Review Board Canada
May 2021
Req # A-2021-09407
Copies of emails to/from/cc'ing Douglas Clark, Tanya Potashnik and Mitchell Levine on negative feedback from the public over the new PMPRB guidelines from June 1, 2019 to December 31, 2020.Organization: Patented Medicine Prices Review Board Canada
May 2021
Req # A-2021-05507
Copies of all communications to/from Douglas Clark regarding the timelines of CADTH and pCPA's drug review process from June 1, 2019 to March 3, 2021.Organization: Patented Medicine Prices Review Board Canada
April 2021
Req # A-2021-05509
Copies of all communications between Douglas Clark and officials in Health Canada's Health Products and Food Branch regarding the drug Trikafta from Vertex Pharmaceuticals.Organization: Patented Medicine Prices Review Board Canada
April 2021